{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:12:33Z","timestamp":1792253553700,"version":"4.4.0"},"reference-count":255,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bbalip.2025.159668","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T23:27:51Z","timestamp":1753313271000},"page":"159668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Polyunsaturated fatty acids in kidney diseases: Navigating the fine line between healing and damage"],"prefix":"10.1016","volume":"1870","author":[{"given":"Mehrdad","family":"Aghasizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Reza","family":"Bahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam M.","family":"Matin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1258\/ebm.2010.009298","article-title":"Genetic variants in the metabolism of omega-6 and omega-3 fatty acids: their role in the determination of nutritional requirements and chronic disease risk","volume":"235","author":"Simopoulos","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0010","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.coph.2013.05.012","article-title":"Resolution phase lipid mediators of inflammation: agonists of resolution","volume":"13","author":"Serhan","year":"2013","journal-title":"Curr. Opin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3945\/an.114.007732","article-title":"Advances in our understanding of oxylipins derived from dietary PUFAs","volume":"6","author":"Melissa Gabbs","year":"2015","journal-title":"Adv. Nutr."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0020","first-page":"212","article-title":"Recent development of lipoxygenase inhibitors as anti-inflammatory agents","volume":"9","author":"Li","year":"2017","journal-title":"Medchemcomm"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0025","article-title":"Dysregulated palmitic acid metabolism promotes the formation of renal calcium-oxalate stones through ferroptosis induced by polyunsaturated fatty acids\/phosphatidic acid","volume":"81","author":"Wang","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0030","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0304-3835(94)90145-7","article-title":"Non-steroidal anti-inflammatory drugs and tumor progression: inhibition of fibroblast hyaluronic acid production by indomethacin and mefenamic acid","volume":"82","author":"Michael August","year":"1994","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbalip.2025.159668_bb0035","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.biochi.2020.09.021","article-title":"Structural considerations on lipoxygenase function, inhibition and crosstalk with nitric oxide pathways","volume":"178","author":"Wood","year":"2020","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0040","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.abb.2010.08.016","article-title":"Molecular enzymology of lipoxygenases","volume":"503","author":"Ivanov","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0045","doi-asserted-by":"crossref","first-page":"F105","DOI":"10.1152\/ajprenal.00214.2021","article-title":"15-Lipoxygenase worsens renal fibrosis, inflammation, and metabolism in a murine model of ureteral obstruction","volume":"322","author":"Montford","year":"2021","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"15","key":"10.1016\/j.bbalip.2025.159668_bb0050","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/ijms20153683","article-title":"Arachidonic acid metabolism and kidney inflammation","volume":"20","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1189\/jlb.4A0815-365RR","article-title":"Lipoxin A4, a 5-lipoxygenase pathway metabolite, modulates immune response during acute respiratory tularemia","volume":"101","author":"Singh","year":"2017","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.120272","article-title":"8-Geranyloxycarbostyril as a potent 15-LOX-1 inhibitor showed great anti-tumor effects against prostate cancer","volume":"293","author":"Aghasizadeh","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bbalip.2025.159668_bb0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00719","article-title":"Regulation and functions of 15-lipoxygenases in human macrophages","volume":"10","author":"Snodgrass","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117293","article-title":"Evaluation of several farnesyloxycarbostyril derivatives as potential 15-LOX-1 inhibitors for prostate cancer treatment","volume":"498","author":"Aghasizadeh","year":"2025","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0075","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1681\/ASN.2017030252","article-title":"Effect of cytochrome P450 metabolites of arachidonic acid in nephrology","volume":"28","author":"Fan","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0080","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.ackd.2015.10.002","article-title":"The effects of CKD on cytochrome P450-mediated drug metabolism","volume":"23","author":"Ladda","year":"2016","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0085","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1042\/bj2380283","article-title":"Regulation of arachidonic acid metabolism by cytochrome P-450 in rabbit kidney","volume":"238","author":"Schwartzman","year":"1986","journal-title":"Biochem. J."},{"issue":"99","key":"10.1016\/j.bbalip.2025.159668_bb0090","article-title":"Dyslipidemia and the progression of renal disease in chronic renal failure patients","volume":"68","author":"Cases","year":"2005","journal-title":"Kidney Int. Suppl."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0095","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4093\/dmj.2023.0067","article-title":"Dyslipidemia in patients with chronic kidney disease: an updated overview","volume":"47","author":"Suh","year":"2023","journal-title":"Diabetes Metab. J."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040722","article-title":"Lipid accumulation and chronic kidney disease","volume":"11","author":"Gai","year":"2019","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.bbalip.2025.159668_bb0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.endonu.2010.06.003","article-title":"Dyslipidemia in renal disease: causes, consequences and treatment","volume":"57","author":"Mesquita","year":"2010","journal-title":"Endocrinol. Nutr."},{"key":"10.1016\/j.bbalip.2025.159668_bb0110","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1046\/j.1523-1755.1999.07113.x","article-title":"Effect of lipoproteins on mesangial cell proliferation","volume":"71","author":"Nishida","year":"1999","journal-title":"Kidney Int. Suppl."},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb0115","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1194\/jlr.P900003-JLR200","article-title":"Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III","volume":"50","author":"Chan","year":"2009","journal-title":"J. Lipid Res."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat. Rev. Nephrol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/foods12050921","article-title":"The development of dyslipidemia in chronic kidney disease and associated cardiovascular damage, and the protective effects of curcuminoids","volume":"12","author":"Ceja-Galicia","year":"2023","journal-title":"Foods"},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0130","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12519-019-00270-2","article-title":"Impact of dyslipidemia on estimated glomerular filtration rate in apparently healthy children and adolescents: the CASPIAN-V study","volume":"15","author":"Moafi","year":"2019","journal-title":"World J. Pediatr."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53064-x","article-title":"Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis","volume":"9","author":"Esmeijer","year":"2019","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0140","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1053\/meta.2001.26737","article-title":"The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in dogs","volume":"50","author":"Davis","year":"2001","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.6061\/clinics\/2017(01)10","article-title":"Omega-3 fatty acid supplementation as an adjunctive therapy in the treatment of chronic kidney disease: a meta-analysis","volume":"72","author":"Hu","year":"2017","journal-title":"Clinics"},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/nu10060775","article-title":"The role of n-3 long chain polyunsaturated fatty acids in cardiovascular disease prevention, and interactions with statins","volume":"10","author":"Bird","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0155","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ajcn\/79.4.558","article-title":"LDL cholesterol-raising effect of low-dose docosahexaenoic acid in middle-aged men and women","volume":"79","author":"Theobald","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21030741","article-title":"Omega-3 versus omega-6 polyunsaturated fatty acids in the prevention and treatment of inflammatory skin diseases","volume":"21","author":"Bali\u0107","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0165","doi-asserted-by":"crossref","first-page":"21167","DOI":"10.3390\/ijms141021167","article-title":"Dietary polyunsaturated fatty acids and inflammation: the role of phospholipid biosynthesis","volume":"14","author":"Raphael","year":"2013","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/nu14102148","article-title":"Association of dietary fish and n-3 unsaturated fatty acid consumption with diabetic nephropathy from a district hospital in northern Taiwan","volume":"14","author":"Lin","year":"2022","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/nu16121918","article-title":"Nutritional strategies against diabetic nephropathy: insights from animal studies and human trials","volume":"16","author":"Zhou","year":"2024","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0180","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1046\/j.1523-1755.2003.00215.x","article-title":"Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease","volume":"64","author":"Ogborn","year":"2003","journal-title":"Kidney Int."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0185","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1177\/0960327112444475","article-title":"Protective effect of \u03c9-3 polyunsaturated fatty acids (PUFAs) on sodium nitroprusside-induced nephrotoxicity and oxidative damage in rat kidney","volume":"31","author":"Khan","year":"2012","journal-title":"Hum. Exp. Toxicol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.ejcn.1601766","article-title":"Long-chain polyunsaturated fatty acids interact with nitric oxide, superoxide anion, and transforming growth factor-\u03b2 to prevent human essential hypertension","volume":"58","author":"Das","year":"2004","journal-title":"Eur. J. Clin. Nutr."},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb0195","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.7326\/0003-4819-138-12-200306170-00029","article-title":"Fish oil therapy in recurrent IgA nephropathy","volume":"138","author":"Ng","year":"2003","journal-title":"Ann. Intern. Med."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb0200","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0955-2863(03)00102-5","article-title":"Beneficial effects of a diet rich in a mixture of n - 6\/n - 3 essential fatty acids and of their metabolites on cyclosporine - nephrotoxicity","volume":"14","author":"Tsipas","year":"2003","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.bbalip.2025.159668_bb0205","article-title":"Omega-3 polyunsaturated fatty acids attenuate fibroblast activation and kidney fibrosis involving MTORC2 signaling suppression","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0210","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pcd.2024.01.002","article-title":"Association between polyunsaturated fatty acids and progression among patients with diabetic kidney disease","volume":"18","author":"Liu","year":"2024","journal-title":"Prim. Care Diabetes"},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb0215","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/01.CIR.0000089129.51288.BA","article-title":"Connective tissue growth factor is a mediator of angiotensin II-induced fibrosis","volume":"108","author":"Rup\u00e9rez","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0220","first-page":"1","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jcp.10298","article-title":"Eicosapentaenoic acid inhibits PDGF-induced mitogenesis and cyclin D1 expression via TGF-beta in mesangial cells","volume":"196","author":"Hida","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0230","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000013328","article-title":"Eicosapentaenoic acid inhibits mitogen-induced endothelin-1 production and DNA synthesis in cultured bovine mesangial cells","volume":"18","author":"Nitta","year":"1998","journal-title":"Am. J. Nephrol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0235","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1152\/ajprenal.00064.2011","article-title":"n-3 fatty acids block TNF-\u03b1-stimulated MCP-1 expression in rat mesangial cells","volume":"300","author":"Diaz Encarnacion","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0240","article-title":"Arachidonic acid potentiates the feedback response of mesangial BKCa channels to angiotensin II","volume":"274","author":"Stockand","year":"1998","journal-title":"Am. J. Phys."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0245","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.ASN.0000045047.44107.0B","article-title":"Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase","volume":"14","author":"Kielar","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0250","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2215\/CJN.10441013","article-title":"Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial","volume":"9","author":"Hoogeveen","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.991059","article-title":"Peroxisome proliferator-activated receptor gamma and its natural agonists in the treatment of kidney diseases","volume":"13","author":"Sharma","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"10","key":"10.1016\/j.bbalip.2025.159668_bb0260","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.3390\/ijms24108838","article-title":"Polyunsaturated fatty acids: Conversion to lipid mediators, roles in inflammatory diseases and dietary sources","volume":"24","author":"Harwood","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"41","key":"10.1016\/j.bbalip.2025.159668_bb0265","doi-asserted-by":"crossref","first-page":"26586","DOI":"10.18632\/oncotarget.25005","article-title":"Prostaglandins in the pathogenesis of kidney diseases","volume":"9","author":"Li","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0270","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1681\/ASN.V2145","article-title":"Functional significance of leukotriene B4 in normal and glomerulonephritic kidneys","volume":"2","author":"Yared","year":"1991","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0275","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ki.2010.377","article-title":"Inhibition of 20-HETE synthesis and action protects the kidney from ischemia\/reperfusion injury","volume":"79","author":"Hoff","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2025.159668_bb0280","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-511X-10-76","article-title":"Lipoxins as biomarkers of lupus and other inflammatory conditions","volume":"10","author":"Das","year":"2011","journal-title":"Lipids Health Dis."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0285","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00467-003-1399-3","article-title":"5-lipoxygenase and leukotriene A4 hydrolase expression in primary nephrotic syndrome","volume":"19","author":"Bakr","year":"2004","journal-title":"Pediatr. Nephrol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0290","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly-139841","article-title":"Platelet indices in children with nephrotic syndrome","volume":"16","author":"Sadeghi-Bojd","year":"2024","journal-title":"Nephro-Urol. Mon."},{"key":"10.1016\/j.bbalip.2025.159668_bb0295","article-title":"Lipoxin A4 restores septic renal function via blocking crosstalk between inflammation and premature senescence","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0300","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10787-022-00942-y","article-title":"Lipoxin A4 regulates M1\/M2 macrophage polarization via FPR2\u2013IRF pathway","volume":"30","author":"Yuan","year":"2022","journal-title":"Inflammopharmacology"},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0305","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","article-title":"Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?","volume":"75","author":"Calder","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.bbalip.2025.159668_bb0310","doi-asserted-by":"crossref","DOI":"10.3390\/nu13114110","article-title":"Adherence to the mediterranean diet improves fatty acids profile in pediatric patients with idiopathic nephrotic syndrome","volume":"13","author":"Stefano","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.bbalip.2025.159668_bb0315","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.646491","article-title":"Effect of \u03c9-3 polyunsaturated fatty acids-derived bioactive lipids on metabolic disorders","volume":"12","author":"Duan","year":"2021","journal-title":"Front. Physiol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","article-title":"Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance","volume":"1851","author":"Calder","year":"2015","journal-title":"BBA Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.bbalip.2025.159668_bb0325","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101978","article-title":"Design of nanoformulation of specialized pro-resolving mediators to facilitate inflammation resolution and disease treatment","volume":"52","author":"Li","year":"2023","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0330","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201936R","article-title":"The leukotriene B4\/BLT1-dependent neutrophil accumulation exacerbates immune complex-mediated glomerulonephritis","volume":"37","author":"Shioda","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.bbalip.2025.159668_bb0335","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/289316","article-title":"A study on clinical and pathologic features in lupus nephritis with mainly IgA deposits and a literature review","volume":"2013","author":"Hongyan","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202842","article-title":"Role of the high-affinity leukotriene B4 receptor signaling in fibrosis after unilateral ureteral obstruction in mice","volume":"14","author":"Kamata","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0345","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/09612033211004727","article-title":"Clinico-pathological associations of serum VCAM-1 and ICAM-1 levels in patients with lupus nephritis","volume":"30","author":"Yu","year":"2021","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0350","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nri.2015.4","article-title":"Specialized pro-resolving mediators: endogenous regulators of infection and inflammation","volume":"16","author":"Basil","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0355","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2013.00013","article-title":"Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: targeting novel lipid mediator pathways in mitigation of acute kidney injury","volume":"4","author":"Hong","year":"2013","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb0360","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1600-6143.2004.00515.x","article-title":"Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?","volume":"4","author":"Meier-Kriesche","year":"2004","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.bbalip.2025.159668_bb0365","doi-asserted-by":"crossref","DOI":"10.1097\/PRS.0000000000011997","article-title":"Effects of omega-3 polyunsaturated fatty acids on inflammation resolution and angiogenesis in fat grafts in a controlled mouse model","author":"Li","year":"2025","journal-title":"Plast. Reconstr. Surg."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0370","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/ajt.15080","article-title":"Effects of marine n-3 fatty acid supplementation in renal transplantation: a randomized controlled trial","volume":"19","author":"Eide","year":"2019","journal-title":"Am. J. Transplant."},{"issue":"11","key":"10.1016\/j.bbalip.2025.159668_bb0375","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1056\/NEJM199309093291105","article-title":"Effect of dietary fish oil on renal function and rejection in cyclosporine-treated recipients of renal transplants","volume":"329","author":"van der Heide","year":"1993","journal-title":"N. Engl. J. Med."},{"issue":"4\u20136","key":"10.1016\/j.bbalip.2025.159668_bb0380","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.plefa.2010.02.013","article-title":"N-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis","volume":"82","author":"Pestka","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0385","first-page":"26","article-title":"ANCA-associated glomerulonephritis: diagnosis and therapy proceedings of the henry shavelle lectureship","volume":"5","author":"Ivkovi\u0107","year":"2025","journal-title":"Glomerular Dis."},{"key":"10.1016\/j.bbalip.2025.159668_bb0390","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ddmod.2014.08.002","article-title":"Lupus nephritis: animal modeling of a complex disease syndrome pathology","volume":"11","author":"McGaha","year":"2014","journal-title":"Drug Discov. Today Dis. Model."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0395","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/1110-161X.157861","article-title":"Urinary lipoxin A4 as a biomarker for systemic lupus erythematosus","volume":"42","author":"Sedky Abdou","year":"2015","journal-title":"Egypt. Rheumatol. Rehabil."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-020-2281-y","article-title":"Lipoxin A4 suppresses angiotensin II type 1 receptor autoantibody in preeclampsia via modulating caspase-1","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbalip.2025.159668_bb0405","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.839248","article-title":"Efferocytosis and its role in inflammatory disorders","volume":"10","author":"Ge","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111299","article-title":"\u03c9-3 polyunsaturated fatty acid alleviates systemic lupus erythematosus by suppressing autoimmunity in a murine model","volume":"126","author":"Liu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0415","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3748\/wjg.v24.i4.461","article-title":"Diet switch and omega-3 hydroxy-fatty acids display differential hepatoprotective effects in an obesity\/nonalcoholic fatty liver disease model in mice","volume":"24","author":"Rodriguez-Echevarria","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0420","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1042\/BST20160474","article-title":"Omega-3 fatty acids and inflammatory processes: from molecules to man","volume":"45","author":"Calder","year":"2017","journal-title":"Biochem. Soc. Trans."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb0425","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.3390\/jcm13082339","article-title":"Urinary biomarkers for lupus nephritis: a systems biology approach","volume":"13","author":"Omer","year":"2024","journal-title":"J. Clin. Med."},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0430","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1172\/JCI31494","article-title":"Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids","volume":"117","author":"Berquin","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0435","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1388-1981(01)00136-6","article-title":"\u03b3-Linolenic acid and eicosapentaenoic acid induce modifications in mitochondrial metabolism, reactive oxygen species generation, lipid peroxidation and apoptosis in Walker 256 rat carcinosarcoma cells","volume":"1533","author":"Colquhoun","year":"2001","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0440","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1007\/s12253-019-00652-x","article-title":"The investigation of lipoxygenases as therapeutic targets in malignant pleural mesothelioma","volume":"26","author":"Oguh-Olayinka","year":"2020","journal-title":"Pathol. Oncol. Res."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0445","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3892\/or.2012.1924","article-title":"Human 5-, 12- and 15-lipoxygenase-1 coexist in kidney but show opposite trends and their balance changes in cancer","volume":"28","author":"Gohara","year":"2012","journal-title":"Oncol. Rep."},{"issue":"20","key":"10.1016\/j.bbalip.2025.159668_bb0450","doi-asserted-by":"crossref","first-page":"6400","DOI":"10.1158\/0008-5472.CAN-11-1261","article-title":"Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway","volume":"71","author":"Daurkin","year":"2011","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0455","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.humpath.2004.04.001","article-title":"15-lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation","volume":"35","author":"Gonzalez","year":"2004","journal-title":"Hum. Pathol."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0460","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/cam4.222","article-title":"15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1\u03b1 expression in human colon cancer cells","volume":"3","author":"Wu","year":"2014","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0465","doi-asserted-by":"crossref","DOI":"10.1186\/s12944-021-01599-2","article-title":"15-Lipoxygenase and its metabolites in the pathogenesis of breast cancer: a double-edged sword","volume":"20","author":"Vaezi","year":"2021","journal-title":"Lipids Health Dis."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0470","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10571-024-01457-6","article-title":"Progress of ferroptosis in ischemic stroke and therapeutic targets","volume":"44","author":"Tian","year":"2024","journal-title":"Cell. Mol. Neurobiol."},{"issue":"11","key":"10.1016\/j.bbalip.2025.159668_bb0475","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.3390\/cancers11111776","article-title":"Deficiency of 15-LOX-1 induces radioresistance through downregulation of macroH2A2 in colorectal cancer","volume":"11","author":"Na","year":"2019","journal-title":"Cancers"},{"issue":"18","key":"10.1016\/j.bbalip.2025.159668_bb0480","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/s41388-024-03016-1","article-title":"The role of human 5-lipoxygenase (5-LO) in carcinogenesis - a question of canonical and non-canonical functions","volume":"43","author":"Kahnt","year":"2024","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0485","first-page":"1","article-title":"Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management","volume":"8","author":"Shyam Sunder","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.bbalip.2025.159668_bb0490","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/jnci\/djr128","article-title":"Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib","volume":"103","author":"Rini","year":"2011","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bbalip.2025.159668_bb0495","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/OTT.S3973","article-title":"Relationship between arachidonic acid pathway and human renal cell carcinoma","volume":"1","author":"Matsuyama","year":"2008","journal-title":"Onco. Targets Ther."},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0500","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2741\/4465","article-title":"Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology","volume":"21","author":"Fan","year":"2016","journal-title":"Front. Biosci. (Landmark Ed.)"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0505","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1124\/jpet.108.140889","article-title":"Expression of CYP4A1 in U251 human glioma cell induces hyperproliferative phenotype in vitro and rapidly growing tumors in vivo","volume":"327","author":"Guo","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.bbalip.2025.159668_bb0510","article-title":"Eicosanoids and cancer","volume":"73","author":"Gomes","year":"2018","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.bbalip.2025.159668_bb0515","first-page":"147","article-title":"Cytochrome 450 metabolites of arachidonic acid (20-HETE, 11,12-EET and 14,15-EET) promote pheochromocytoma cell growth and tumor associated angiogenesis","volume":"171\u2013172","author":"Cecilia","year":"2020","journal-title":"Biochimie"},{"issue":"18","key":"10.1016\/j.bbalip.2025.159668_bb0520","doi-asserted-by":"crossref","first-page":"15671","DOI":"10.1074\/jbc.M110806200","article-title":"Cytochrome P450 2C9-induced endothelial cell proliferation involves induction of mitogen-activated protein (MAP) kinase phosphatase-1, inhibition of the c-Jun N-terminal kinase, and up-regulation of cyclin D1","volume":"277","author":"Potente","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0525","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cncr.21661","article-title":"Maximal COX-2 immunostaining and clinical response to celecoxib and interferon alpha therapy in metastatic renal cell carcinoma","volume":"106","author":"Rini","year":"2006","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0530","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/bjc.2012.591","article-title":"Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts","volume":"108","author":"Wang","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbalip.2025.159668_bb0535","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.molmet.2018.05.013","article-title":"PPAR\u03b3 is dispensable for clear cell renal cell carcinoma progression","volume":"14","author":"Sanchez","year":"2018","journal-title":"Mol. Metab."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0540","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1745-7254.2005.00753.x","article-title":"Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines","volume":"26","author":"Yang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bbalip.2025.159668_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1184794","article-title":"The role of peroxisome proliferator-activated receptors in the tumor microenvironment, tumor cell metabolism, and anticancer therapy","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0550","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5201759","article-title":"The role of phospholipase C signaling in macrophage-mediated inflammatory response","author":"Zhu","year":"2018","journal-title":"J. Immunol. Res."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0555","first-page":"1","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0560","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney","volume":"34","author":"N\u00f8rregaard","year":"2015","journal-title":"Kidney Res. Clin. Pract."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0565","article-title":"Mechanism for the reactivation of the peroxidase activity of human cyclooxygenases: investigation using phenol as a reducing cosubstrate","volume":"10","author":"Yang","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0570","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07.008","article-title":"Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors","volume":"1851","author":"Kawahara","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0575","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clim.2004.09.008","article-title":"15d-PGJ2: the anti-inflammatory prostaglandin?","volume":"114","author":"Scher","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0580","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.vph.2015.04.009","article-title":"Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: role of thromboxane and purinergic receptors","volume":"73","author":"Zhou","year":"2015","journal-title":"Vasc. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0585","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.tips.2014.03.001","article-title":"COX-2-derived endocannabinoid metabolites as novel inflammatory mediators","volume":"35","author":"Alhouayek","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbalip.2025.159668_bb0590","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3389\/fphys.2018.01358","article-title":"Invalidation of microsomal prostaglandin E synthase-1 (mPGES-1) reduces diet-induced low-grade inflammation and adiposity","volume":"9","author":"Pierre","year":"2018","journal-title":"Front. Physiol."},{"issue":"21","key":"10.1016\/j.bbalip.2025.159668_bb0595","doi-asserted-by":"crossref","first-page":"13926","DOI":"10.1073\/pnas.162468699","article-title":"COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic\/antipyretic drugs: cloning, structure, and expression","volume":"99","author":"Chandrasekharan","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0600","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.bbalip.2014.08.012","article-title":"5-Lipoxygenase, a key enzyme for leukotriene biosynthesis in health and disease","volume":"1851","author":"R\u00e5dmark","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"15","key":"10.1016\/j.bbalip.2025.159668_bb0605","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1016\/j.bmcl.2016.06.025","article-title":"Kinetic investigation of human 5-lipoxygenase with arachidonic acid","volume":"26","author":"Mittal","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"27","key":"10.1016\/j.bbalip.2025.159668_bb0610","doi-asserted-by":"crossref","first-page":"19233","DOI":"10.1016\/S0021-9258(18)41766-8","article-title":"Metabolism of 5(S)-hydroxy-6,8,11,14-eicosatetraenoic acid and other 5(S)-hydroxyeicosanoids by a specific dehydrogenase in human polymorphonuclear leukocytes","volume":"267","author":"Powell","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0615","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.bbalip.2014.10.008","article-title":"Biosynthesis, biological effects, and receptors of hydroxyeicosatetraenoic acids (HETEs) and oxoeicosatetraenoic acids (oxo-ETEs) derived from arachidonic acid","volume":"1851","author":"Powell","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"48","key":"10.1016\/j.bbalip.2025.159668_bb0620","doi-asserted-by":"crossref","first-page":"6726","DOI":"10.1021\/acs.biochem.8b00889","article-title":"5 S,15 S-Dihydroperoxyeicosatetraenoic acid (5,15-diHpETE) as a lipoxin intermediate: reactivity and kinetics with human leukocyte 5-lipoxygenase, platelet 12-lipoxygenase, and reticulocyte 15-lipoxygenase-1","volume":"57","author":"Green","year":"2018","journal-title":"Biochemistry"},{"issue":"27","key":"10.1016\/j.bbalip.2025.159668_bb0625","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.1021\/bi401621d","article-title":"ATP allosterically activates the human 5-lipoxygenase molecular mechanism of arachidonic acid and 5(S)-Hydroperoxy-6(E),8(Z),11(Z),14(Z)-eicosatetraenoic acid","volume":"53","author":"Smyrniotis","year":"2014","journal-title":"Biochemistry"},{"issue":"9","key":"10.1016\/j.bbalip.2025.159668_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007250","article-title":"12\/15-lipoxygenase is required for the early onset of high fat diet-induced adipose tissue inflammation and insulin resistance in mice","volume":"4","author":"Sears","year":"2009","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.bbalip.2025.159668_bb0635","doi-asserted-by":"crossref","first-page":"7937","DOI":"10.3390\/ijms22157937","article-title":"Targeting mammalian 5-lipoxygenase by dietary phenolics as an anti-inflammatory mechanism: a systematic review","volume":"22","author":"Gim\u00e9nez-Bastida","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0640","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3390\/biom11050717","article-title":"Regulation of tissue inflammation by 12-lipoxygenases","volume":"11","author":"Kulkarni","year":"2021","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0645","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2008.07.033","article-title":"New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development","volume":"77","author":"Moreno","year":"2009","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0650","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbalip.2014.10.002","article-title":"Mammalian lipoxygenases and their biological relevance","volume":"1851","author":"K\u00fchn","year":"2015","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"17","key":"10.1016\/j.bbalip.2025.159668_bb0655","doi-asserted-by":"crossref","first-page":"13282","DOI":"10.3390\/ijms241713282","article-title":"Promising anti-inflammatory tools: biomedical efficacy of lipoxins and their synthetic pathways","volume":"24","author":"Chi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0660","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/092986709787002727","article-title":"Structure of cytochrome p450s and personalized drug","volume":"16","author":"Wang","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbalip.2025.159668_bb0665","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00239","article-title":"Inside epoxyeicosatrienoic acids and cardiovascular disease","volume":"5","author":"Tacconelli","year":"2014","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0670","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/002215540405200403","article-title":"Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues","volume":"52","author":"Enayetallah","year":"2004","journal-title":"J. Histochem. Cytochem."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0675","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00216-008-2308-1","article-title":"Direct and simultaneous profiling of epoxyeicosatrienoic acid enantiomers by capillary tandem column chiral-phase liquid chromatography with dual online photodiode array and tandem mass spectrometric detection","volume":"392","author":"Kiss","year":"2008","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.bbalip.2025.159668_bb0680","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1146\/annurev-pharmtox-011112-140244","article-title":"Impact of soluble epoxide hydrolase and epoxyeicosanoids on human health","volume":"53","author":"Morisseau","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"11","key":"10.1016\/j.bbalip.2025.159668_bb0685","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/01.RES.87.11.992","article-title":"Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids","volume":"87","author":"Yu","year":"2000","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0690","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/abbi.1998.0806","article-title":"Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid","volume":"357","author":"Luo","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0695","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1074\/jbc.271.7.3460","article-title":"Molecular cloning and expression of CYP2J2, a human cytochrome P450 arachidonic acid epoxygenase highly expressed in heart","volume":"271","author":"Wu","year":"1996","journal-title":"J. Biol. Chem."},{"issue":"7503","key":"10.1016\/j.bbalip.2025.159668_bb0700","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0705","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0272-6386(12)70273-1","article-title":"Omega-3 fatty acid supplementation in clinical and experimental lupus nephritis","volume":"23","author":"Clark","year":"1994","journal-title":"Am. J. Kidney Dis."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0710","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nri2294","article-title":"Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators","volume":"8","author":"Serhan","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"5\u20136","key":"10.1016\/j.bbalip.2025.159668_bb0715","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.plefa.2009.09.004","article-title":"Anti-inflammatory and pro-resolving properties of benzo-lipoxin A4 analogs","volume":"81","author":"Sun","year":"2009","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0720","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1097\/01.ASN.0000015795.74094.91","article-title":"15-Epi-16-(para-fluorophenoxy)-lipoxin A4-methyl ester, a synthetic analogue of 15-epi-lipoxin A4, is protective in experimental ischemic acute renal failure","volume":"13","author":"Leonard","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070029","article-title":"20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway","volume":"8","author":"Eid","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2025.159668_bb0730","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/bs.apha.2023.01.002","article-title":"20-Hydroxyeicosatetraenoic acid (20-HETE): bioactions, receptors, vascular function, cardiometabolic disease and beyond","volume":"97","author":"Pascale","year":"2023","journal-title":"Adv. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb0735","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jpain.2022.02.011","article-title":"Activation of 20-HETE synthase triggers oxidative injury and peripheral nerve damage in type 2 diabetic mice","volume":"23","author":"Haddad","year":"2022","journal-title":"J. Pain"},{"issue":"21","key":"10.1016\/j.bbalip.2025.159668_bb0740","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.3390\/ijms242115520","article-title":"Pioglitazone protects tubular epithelial cells during kidney fibrosis by attenuating miRNA dysregulation and autophagy dysfunction induced by TGF-\u03b2","volume":"24","author":"Manz\u00e9ger","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.bbalip.2025.159668_bb0745","doi-asserted-by":"crossref","first-page":"7671","DOI":"10.1073\/pnas.0409271102","article-title":"Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis","volume":"102","author":"Arita","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bbalip.2025.159668_bb0750","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1243675","article-title":"Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies","volume":"14","author":"Feng","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0755","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00441-017-2727-4","article-title":"Platelet-neutrophil interactions as drivers of inflammatory and thrombotic disease","volume":"371","author":"Lisman","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.bbalip.2025.159668_bb0760","article-title":"A new perspective on proteinuria and drug therapy for diabetic kidney disease","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0765","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0891-5849(03)00386-1","article-title":"Activation of p38 mitogen-activated protein kinase\/cytosolic phospholipase A2 cascade in hydroperoxide-stressed platelets","volume":"35","author":"Coulon","year":"2003","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbalip.2025.159668_bb0770","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2018.10.010","article-title":"Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications","volume":"195","author":"Dobrian","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0775","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1056","article-title":"Fatty acids negatively regulate platelet function through formation of noncanonical 15-lipoxygenase-derived eicosanoids","volume":"11","author":"Yamaguchi","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"issue":"4995","key":"10.1016\/j.bbalip.2025.159668_bb0780","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1126\/science.1846705","article-title":"Effect of cytochrome P450 arachidonate metabolites on ion transport in rabbit kidney loop of Henle","volume":"251","author":"Escalante","year":"1991","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0785","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.HYP.0000255753.89363.47","article-title":"Elevations in renal interstitial hydrostatic pressure and 20-hydroxyeicosatetraenoic acid contribute to pressure natriuresis","volume":"49","author":"Williams","year":"2007","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0790","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmaceutics9010009","article-title":"Clinical implications of 20-hydroxyeicosatetraenoic acid in the kidney, liver, lung and brain: an emerging therapeutic target","volume":"9","author":"Elshenawy","year":"2017","journal-title":"Pharmaceutics"},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0795","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/ki.2008.600","article-title":"Protective effect of 20-HETE analogues in experimental renal ischemia reperfusion injury","volume":"75","author":"Regner","year":"2009","journal-title":"Kidney Int."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0800","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.2337\/db08-1536","article-title":"Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases","volume":"58","author":"Eid","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.bbalip.2025.159668_bb0805","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2022.04.013","article-title":"Urinary 20-HETE: a prospective non-invasive prognostic and diagnostic marker for diabetic kidney disease","volume":"44","author":"Houeiss","year":"2023","journal-title":"J. Adv. Res."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0810","doi-asserted-by":"crossref","first-page":"F393","DOI":"10.1152\/ajprenal.00186.2015","article-title":"TRPC6 channel as an emerging determinant of the podocyte injury susceptibility in kidney diseases","volume":"309","author":"Ilatovskaya","year":"2015","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"5 Pt 2","key":"10.1016\/j.bbalip.2025.159668_bb0815","article-title":"Postischemic renal injury is mediated by neutrophils and leukotrienes","volume":"256","author":"Klausner","year":"1989","journal-title":"Am. J. Phys."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0820","doi-asserted-by":"crossref","first-page":"F732","DOI":"10.1152\/ajprenal.00262.2018","article-title":"Inhibition of 5-lipoxygenase decreases renal fibrosis and progression of chronic kidney disease","volume":"316","author":"Montford","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0825","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1073\/pnas.97.2.823","article-title":"An in vivo approach showing the chemotactic activity of leukotriene B4 in acute renal ischemic-reperfusion injury","volume":"97","author":"Noiri","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0830","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1172\/JCI113351","article-title":"Neutrophil adherence to human endothelium in vitro occurs by CDw18 (Mo1, MAC-1\/LFA-1\/GP 150,95) glycoprotein-dependent and -independent mechanisms","volume":"81","author":"Zimmerman","year":"1988","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0835","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.semnephrol.2010.03.005","article-title":"Macrophages, dendritic cells, and kidney ischemia-reperfusion injury","volume":"30","author":"Li","year":"2010","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0840","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s40620-016-0297-2","article-title":"Montelukast as an add-on treatment in steroid dependant nephrotic syndrome, randomised-controlled trial","volume":"29","author":"Zedan","year":"2016","journal-title":"J. Nephrol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb0845","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1111\/j.1523-1755.2004.00487.x","article-title":"Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease","volume":"65","author":"Kieran","year":"2004","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb0850","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/cdd.2009.220","article-title":"Lipoxin A4 impairment of apoptotic signaling in macrophages: implication of the PI3K\/Akt and the ERK\/Nrf-2 defense pathways","volume":"17","author":"Prieto","year":"2010","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0855","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2353\/ajpath.2009.080671","article-title":"Elevated expressions of 15-lipoxygenase and lipoxin A4 in children with acute poststreptococcal glomerulonephritis","volume":"174","author":"Wu","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0860","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0002-9440(10)62043-3","article-title":"Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells","volume":"167","author":"Rodgers","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0865","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2147\/JIR.S301292","article-title":"LXA4 inhibits lipopolysaccharide-induced inflammatory cell accumulation by resident macrophages in mice","volume":"14","author":"Mei","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0870","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-27194-7","article-title":"Lipoxin A4 attenuates the inflammatory response in stem cells of the apical papilla via ALX\/FPR2","volume":"8","author":"Gaudin","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0875","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2017101112","article-title":"Lipoxins regulate the early growth response-1 network and reverse diabetic kidney disease","volume":"29","author":"Brennan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0880","article-title":"Calycosin attenuates renal ischemia\/reperfusion injury by suppressing NF-\u03baB mediated inflammation via PPAR\u03b3\/EGR1 pathway","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb0885","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00109-016-1403-6","article-title":"Egr-1 deficiency protects from renal inflammation and fibrosis","volume":"94","author":"Ho","year":"2016","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"7395","key":"10.1016\/j.bbalip.2025.159668_bb0890","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","article-title":"Infection regulates pro-resolving mediators that lower antibiotic requirements","volume":"484","author":"Chiang","year":"2012","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0895","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4049\/jimmunol.1101029","article-title":"Regulation of immune responses by prostaglandin E2","volume":"188","author":"Kalinski","year":"2012","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb0900","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1681\/ASN.2013090980","article-title":"Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy","volume":"26","author":"Gangadhariah","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0905","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.949407","article-title":"Therapeutic activity of lipoxin A4 in TiO2-induced arthritis in mice: NF-\u03baB and Nrf2 in synovial fluid leukocytes and neuronal TRPV1 mechanisms","volume":"14","author":"Saraiva-Santos","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0910","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768133","article-title":"Regulation of T-cell immune responses by pro-resolving lipid mediators","volume":"12","author":"Perez-Hernandez","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-04883-w","article-title":"Types of necroinflammation, the effect of cell death modalities on sterile inflammation","volume":"13","author":"M\u00e1zl\u00f3","year":"2022","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0920","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0958-1669(99)00030-0","article-title":"Peroxisome proliferator-activated receptors: three isotypes for a multitude of functions","volume":"10","author":"Michalik","year":"1999","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.bbalip.2025.159668_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.bbalip.2025.159668_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106786","article-title":"Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD)","volume":"192","author":"Qiu","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb0935","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3390\/cells12121572","article-title":"Recent insights into the role of PPARs in disease","volume":"12","author":"Wagner","year":"2023","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0940","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1053\/j.ajkd.2009.11.013","article-title":"Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis","volume":"55","author":"Sarafidis","year":"2010","journal-title":"Am. J. Kidney Dis."},{"issue":"9","key":"10.1016\/j.bbalip.2025.159668_bb0945","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1073\/pnas.97.9.4844","article-title":"15-Deoxy-\u039412,14-prostaglandin J2 inhibits multiple steps in the NF-\u03baB signaling pathway","volume":"97","author":"Straus","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0950","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.bbrc.2005.09.085","article-title":"Covalent binding of 15-deoxy-delta12,14-prostaglandin J 2 to PPAR\u03b3","volume":"337","author":"Soares","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb0955","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/2042018810375656","article-title":"Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis","volume":"1","author":"Vangaveti","year":"2010","journal-title":"Ther. Adv. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0960","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1194\/jlr.M072587","article-title":"NLRP3 inflammasome as a novel target for docosahexaenoic acid metabolites to abrogate glomerular injury","volume":"58","author":"Li","year":"2017","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bbalip.2025.159668_bb0965","article-title":"Targeting peroxisome proliferator-activated receptors using thiazolidinediones: strategy for design of novel antidiabetic drugs","volume":"2017","author":"Thangavel","year":"2017","journal-title":"Int. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb0970","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/cells9010252","article-title":"PPAR\u03b3-independent side effects of thiazolidinediones on mitochondrial redox state in rat isolated hearts","volume":"9","author":"Riess","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb0975","first-page":"636","article-title":"Accelerated renal disease is associated with the development of metabolic syndrome in a glucolipotoxic mouse model","volume":"5","author":"Mart\u00ednez-Garc\u00eda","year":"2012","journal-title":"MM Dis. Models Mech."},{"issue":"40","key":"10.1016\/j.bbalip.2025.159668_bb0980","doi-asserted-by":"crossref","first-page":"64690","DOI":"10.18632\/oncotarget.11811","article-title":"Renal tubular epithelium-targeted peroxisome proliferatoractivated receptor-\u03b3 maintains the epithelial phenotype and antagonizes renal fibrogenesis","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.bbalip.2025.159668_bb0985","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142291","article-title":"Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes","volume":"10","author":"Mart\u00ednez-Garc\u00eda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbalip.2025.159668_bb0990","article-title":"PPAR\u03b3 mediates the anti-epithelial-mesenchymal transition effects of FGF1\u0394HBS in chronic kidney diseases via inhibition of TGF-\u03b21\/SMAD3 signaling","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb0995","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1159\/000486056","article-title":"Rosiglitazone inhibits angiotensin II-induced proliferation of glomerular mesangial cells via the G\u03b1q\/Plc\u03b24\/TRPC signaling pathway","volume":"44","author":"Wei","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb1000","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1055\/s-0032-1314836","article-title":"Effect of thiazolidinedione treatment on proteinuria and renal hemodynamic in type 2 diabetic patients with overt nephropathy","volume":"44","author":"Pistrosch","year":"2012","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb1005","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171474","article-title":"Nephropathy in Pparg-null mice highlights PPAR\u03b3 systemic activities in metabolism and in the immune system","volume":"12","author":"Toffoli","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb1010","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1007\/s00210-024-03004-y","article-title":"Alleviation of pulmonary fibrosis by the dual PPAR agonist saroglitazar and breast milk mesenchymal stem cells via modulating TGF\u00df\/SMAD pathway","volume":"397","author":"Attia","year":"2024","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bbalip.2025.159668_bb1015","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3389\/fphys.2018.01033","article-title":"Klotho and PPAR gamma activation mediate the renoprotective effect of losartan in the 5\/6 nephrectomy model","volume":"9","author":"Maquigussa","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bbalip.2025.159668_bb1020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ebiom.2019.10.023","article-title":"Uncoupling protein 1 inhibits mitochondrial reactive oxygen species generation and alleviates acute kidney injury","volume":"49","author":"Jia","year":"2019","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb1025","article-title":"Oxidative stress and ischemia\/reperfusion injury in kidney transplantation: focus on ferroptosis, mitophagy and new antioxidants","volume":"11","author":"Granata","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1030","doi-asserted-by":"crossref","DOI":"10.3892\/br.2022.1584","article-title":"Pioglitazone modulates immune activation and ameliorates inflammation induced by injured renal tubular epithelial cells via PPAR\u03b3\/miRNA-124\/STAT3 signaling","volume":"18","author":"El Gazzar","year":"2022","journal-title":"Biomed. Rep."},{"issue":"1\u20132","key":"10.1016\/j.bbalip.2025.159668_bb1035","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11010-016-2718-x","article-title":"Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats","volume":"417","author":"Singh","year":"2016","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbalip.2025.159668_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172695","article-title":"Pioglitazone protects tubular cells against hypoxia\/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway","volume":"863","author":"Xi","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb1045","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1093\/ndt\/gfi172","article-title":"Chronic allograft nephropathy: expression and localization of PAI-1 and PPAR-gamma","volume":"20","author":"Revelo","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb1050","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.2001.0590051899.x","article-title":"Peroxisome proliferator-activated receptor-gamma agonist troglitazone protects against nondiabetic glomerulosclerosis in rats","volume":"59","author":"Ma","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.bbalip.2025.159668_bb1055","doi-asserted-by":"crossref","DOI":"10.1155\/2007\/62641","article-title":"Peroxisome proliferator-activated receptor-\u03b3 (PPAR-\u03b3) agonists attenuate the profibrotic response induced by TGF-\u03b21 in renal interstitial fibroblasts","volume":"2007","author":"Wang","year":"2007","journal-title":"Mediat. Inflamm."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb1060","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.2215\/CJN.10471013","article-title":"Association of anti-PLA\u2082R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy","volume":"9","author":"Bech","year":"2014","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"8","key":"10.1016\/j.bbalip.2025.159668_bb1065","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.bbalip.2025.159668_bb1070","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s40265-017-0751-z","article-title":"Working towards an appropriate use of ibuprofen in children: an evidence-based appraisal","volume":"77","author":"de Martino","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1075","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1742-7843.2012.00882.x","article-title":"Licofelone inhibits interleukin-18-induced pro-inflammatory cytokine release and cellular proliferation in human mesangial cells","volume":"111","author":"Wu","year":"2012","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1080","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2165\/00003495-199300461-00066","article-title":"Renal effects of nimesulide in furosemide-treated subjects","volume":"46 Suppl 1","author":"Steinh\u00e4uslin","year":"1993","journal-title":"Drugs"},{"issue":"17","key":"10.1016\/j.bbalip.2025.159668_bb1085","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa020798","article-title":"Aspirin and mortality from coronary bypass surgery","volume":"347","author":"Mangano","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1090","article-title":"Neutrophil: lymphocyte ratio and intraoperative use of ketorolac or diclofenac are prognostic factors in different cohorts of patients undergoing breast, lung, and kidney cancer surgery","volume":"20","author":"Forget","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1095","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/FJC.0b013e318298e460","article-title":"Anti-inflammatory effects of \u03c9-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension","volume":"62","author":"Ulu","year":"2013","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb1100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2169\/internalmedicine.52.8323","article-title":"Effects of combination therapy with renin-angiotensin system inhibitors and eicosapentaenoic acid on IgA nephropathy","volume":"52","author":"Moriyama","year":"2013","journal-title":"Intern. Med."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb1105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.4161\/onci.1.2.18502","article-title":"Enhanced 15-lipoxygenase activity and elevated eicosanoid production in kidney tumor microenvironment contribute to the inflammation and immune suppression","volume":"1","author":"Kusmartsev","year":"2012","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1110","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3233\/KCA-180027","article-title":"Impact of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on outcomes in patients with metastatic renal cell carcinoma","volume":"2","author":"Hamieh","year":"2018","journal-title":"Kidney Cancer"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1349-7006.2010.01756.x","article-title":"Phase-II trial of combination treatment of interferon-\u03b1, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma","volume":"102","author":"Tatokoro","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbalip.2025.159668_bb1120","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ejmech.2019.06.060","article-title":"Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells","volume":"179","author":"Selka","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb1125","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1021\/jm00108a039","article-title":"Novel caffeic acid derivatives: extremely potent inhibitors of 12-lipoxygenase","volume":"34","author":"Cho","year":"1991","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb1130","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1745-7254.2005.00753.x","article-title":"Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines","volume":"26","author":"Yang","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1135","first-page":"41","article-title":"Expression of 12-lipoxygenase in human renal cell carcinoma and growth prevention by its inhibitor","volume":"13","author":"Yoshimura","year":"2004","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bbalip.2025.159668_bb1140","article-title":"Cysteinyl leukotriene receptor antagonists decrease cancer risk in asthma patients","volume":"6","author":"Tsai","year":"2016","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb1145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073567","article-title":"Zafirlukast induces VHL- and HIF-2\u03b1-dependent oxidative cell death in 786-O clear cell renal carcinoma cells","volume":"23","author":"Wolf","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173201","article-title":"Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: a single-centre study over 14 years","volume":"12","author":"Pourcine","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1155","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-021-02372-4","article-title":"Prednisolone treatment in acute interstitial nephritis (PRAISE) - protocol for the randomized controlled trial","volume":"22","author":"Mose","year":"2021","journal-title":"BMC Nephrol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb1160","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00467-019-04207-9","article-title":"Drug-induced tubulointerstitial nephritis: hypersensitivity and necroinflammatory pathways","volume":"35","author":"Eddy","year":"2020","journal-title":"Pediatr. Nephrol."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1165","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1080\/0886022X.2022.2068442","article-title":"Analysis of glomerular PLA2R efficacy in evaluating the prognosis of idiopathic membranous nephropathy in the background of different serum anti-PLA2R levels","volume":"44","author":"Sun","year":"2022","journal-title":"Ren. Fail."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1170","doi-asserted-by":"crossref","DOI":"10.1186\/cc7894","article-title":"Determinants of postoperative acute kidney injury","volume":"13","author":"Abelha","year":"2009","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12245-025-00835-1","article-title":"Aspirin increases the risk of acute kidney injury in critical patients with chest trauma: a retrospective cohort study","volume":"18","author":"Huang","year":"2025","journal-title":"Int. J. Emerg. Med."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb1180","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejim.2015.03.008","article-title":"Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies","volume":"26","author":"Ungprasert","year":"2015","journal-title":"Eur. J. Intern. Med."},{"issue":"Suppl. 90","key":"10.1016\/j.bbalip.2025.159668_bb1185","first-page":"62","article-title":"Safety of nonsteroidal antiinflammatory drugs and\/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic review","volume":"Suppl","author":"Colebatch","year":"2012","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb1190","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","article-title":"Membranous nephropathy and nonsteroidal anti-inflammatory agents","volume":"62","author":"Nawaz","year":"2013","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.bbalip.2025.159668_bb1195","article-title":"Lipoxin A4 yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling","author":"Koudelka","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.bbalip.2025.159668_bb1200","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/89759","article-title":"Lipid mediator class switching during acute inflammation: signals in resolution","volume":"2","author":"Levy","year":"2001","journal-title":"Nat. Immunol."},{"issue":"9","key":"10.1016\/j.bbalip.2025.159668_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092553","article-title":"Omega-3 fatty acids attenuate renal fibrosis via AMPK-mediated autophagy flux activation","volume":"11","author":"Han","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbalip.2025.159668_bb1210","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejphar.2018.06.010","article-title":"Conflicting roles of 20-HETE in hypertension and renal end organ damage","volume":"833","author":"Zhang","year":"2018","journal-title":"Eur. J. Pharmacol."},{"issue":"24","key":"10.1016\/j.bbalip.2025.159668_bb1215","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1016\/S0024-3205(03)00180-2","article-title":"Role for thromboxane A2 from glomerular thrombi in nephropathy with type 2 diabetic rats","volume":"72","author":"Okumura","year":"2003","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.bbalip.2025.159668_bb1220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12014-021-09315-z","article-title":"Rational selection of a biomarker panel targeting unmet clinical needs in kidney injury","volume":"18","author":"van Duijl","year":"2021","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.bbalip.2025.159668_bb1225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mam.2017.08.002","article-title":"New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration","volume":"64","author":"Serhan","year":"2018","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.bbalip.2025.159668_bb1230","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.683247","article-title":"Targeted drug delivery systems for kidney diseases","volume":"9","author":"Huang","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"11","key":"10.1016\/j.bbalip.2025.159668_bb1235","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.semnephrol.2004.01.004","article-title":"The role of fish oil\/omega-3 fatty acids in the treatment of IgA nephropathy","volume":"24","author":"Donadio","year":"2004","journal-title":"Semin. Nephrol."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb1245","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1681\/ASN.V124791","article-title":"A randomized trial of high-dose compared with low-dose omega-3 fatty acids in severe IgA nephropathy","volume":"12","author":"Donadio","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"issue":"5","key":"10.1016\/j.bbalip.2025.159668_bb1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154683","article-title":"Effects of omega-3 fatty acid supplementation on diabetic nephropathy progression in patients with diabetes and hypertriglyceridemia","volume":"11","author":"Han","year":"2016","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bbalip.2025.159668_bb1255","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1096\/fj.09-133421","article-title":"Increasing intakes of the long-chain \u03c9-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men","volume":"23","author":"Guillot","year":"2009","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.bbalip.2025.159668_bb1260","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.plefa.2010.06.007","article-title":"Bioavailability of marine n-3 fatty acid formulations","volume":"83","author":"Dyerberg","year":"2010","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"issue":"6","key":"10.1016\/j.bbalip.2025.159668_bb1265","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.jrn.2009.05.007","article-title":"Effect of intradialytic intravenous administration of \u03c9-3 fatty acids on nutritional status and inflammatory response in hemodialysis patients: a pilot study","volume":"19","author":"Szklarek-Kubicka","year":"2009","journal-title":"J. Ren. Nutr."},{"issue":"4","key":"10.1016\/j.bbalip.2025.159668_bb1270","first-page":"432","article-title":"Recent advances in nanotherapeutics for the treatment and prevention of acute kidney injury","volume":"16","author":"Yu","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.bbalip.2025.159668_bb1275","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.clnu.2019.02.041","article-title":"Effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kidney disease: systematic review and meta-analysis of randomized controlled trials","volume":"39","author":"Saglimbene","year":"2020","journal-title":"Clin. Nutr."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198125000769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388198125000769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:06:15Z","timestamp":1756281975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388198125000769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":255,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1388198125000769"],"URL":"https:\/\/doi.org\/10.1016\/j.bbalip.2025.159668","relation":{},"ISSN":["1388-1981"],"issn-type":[{"value":"1388-1981","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyunsaturated fatty acids in kidney diseases: Navigating the fine line between healing and damage","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbalip.2025.159668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"159668"}}